Correlation Between Dosimetric Parameters and Late Rectal and Urinary Toxicities in Patients Treated With High-Dose-Rate Brachytherapy Used as Monotherapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1003-1007

  Konishi, Koji ^a   Yoshioka, Yasuo ^a   Isohashi, Fumiaki ^a   Sumida, Iori ^a   Kawaguchi, Yoshifumi ^a   Kotsuma, Tadayuki ^a   Adachi, Kana ^a   Morimoto, Masahiro ^a   Fukuda, Shoichi ^a   Inoue, Takehiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dose volume constraint; High dose rate brachytherapy; Late toxicity; Monotherapy; Prostate cancer

Indexed keywords

DOSE-VOLUME; DOSIMETRIC PARAMETER; HIGH-DOSE RATE BRACHYTHERAPY; MONO-THERAPY; OSAKA UNIVERSITY; PROSTATE CANCERS; RECTAL TOXICITY; UP TIME;

DOSIMETERS; DOSIMETRY; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY;

TOXICITY;

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CORRELATIONAL STUDY; DOSIMETRY; DYSURIA; FOLLOW UP; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM; RECTUM HEMORRHAGE; TREATMENT OUTCOME; URETHRORECTAL FISTULA; URINARY FREQUENCY; URINARY TRACT; ADENOCARCINOMA; BLOOD; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; EVALUATION; GASTROINTESTINAL HEMORRHAGE; METHODOLOGY; MICTURITION DISORDER; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; TUMOR VOLUME; URETHRA;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; TUMOR BURDEN; URETHRA; URINATION DISORDERS;

EID: 70449721429     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.051     Document Type: Article

References (22)

1. Martinez A., Gonzalez J., Stromberg J., et al. Conformal prostate brachytherapy: Initial experience of a Phase I/II dose escalating trial. Int J Radiat Oncol Biol Phys 33 (1995) 1019-1027
2. Borghede G., Hedelin H., Holmang S., et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 44 (1997) 237-244
3. Mate T.P., Gottesman J.E., Hatton J., et al. High dose-rate afterloading Ir-192 prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
4. Dinges S., Deger S., Koswig S., et al. High-dose rate interstitial with external beam irradiation for localized prostate cancer-Results of a prospective trial. Radiother Oncol 48 (1998) 197-202
5. Damore S.J., Syed A.M., Puthawala A.A., et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1205-1211
6. Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
7. Pellizzon A.C., Nadalin W., Salvajoli J.V., et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 66 (2003) 167-172
8. Hiratsuka J., Jo Y., Yoshida K., et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 684-690
9. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate interstitial brachytherapy as monotherapy for localized prostate cancer: Treatment description and preliminary results of a Phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48 (2000) 675-681
10. Martinez A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 49 (2001) 61-69
11. Martin T., Baltas D., Kurek R., et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 180 (2004) 225-232
12. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 56 (2003) 213-220
13. Yoshioka Y., Konishi K., Oh R., et al. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiother Oncol 80 (2006) 62-68
14. Hsu I.C., Pickett B., Shinohara K., et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys 46 (2000) 851-858
15. Akimoto T., Katoh H., Kitamoto Y., et al. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 65 (2006) 364-370
16. Sanguineti G., Agostinelli S., Foppiano F., et al. Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma. Br J Cancer 86 (2002) 1843-1847
17. Snyder K.M., Stock R.G., Hong S.M., et al. Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50 (2001) 335-341
18. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy_3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
19. Lessard E., and Pouliot J. Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys 28 (2001) 773-779
20. Yoshioka Y., Nishimura T., Kamata M., et al. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: A dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization. Radiother Oncol 75 (2005) 311-317
21. Sumida I., Shiomi H., Yoshioka Y., et al. Optimization of dose distribution for HDR brachytherapy of the prostate using attraction-repulsion model. Int J Radiat Oncol Biol Phys 64 (2006) 643-649
22. Akimoto T., Katoh H., Kitamoto Y., et al. Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: Comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization. Int J Radiat Oncol Biol Phys 64 (2006) 1360-1366